November 16, 2012
A pair of Abiomed Inc. investors sued the cardiac-device maker in Massachusetts federal court Friday, claiming the company lied about a U.S. Food and Drug Administration investigation into ad campaigns for one of its products, which artificially inflated stock values before they plummeted as word of the probe got out.